During the period from January 2002 to March 2007, infections by melanized fungi were identified with greater frequency in aquarium-maintained leafy seadragons (Phycodurus eques) and weedy seadragons (Phyllopteryx taeniolatus), pivotal species to the educational and environmental concerns of the aquarium industry and conservation groups. The objective of this study was to characterize the patho...

Information about the potential for crop–wild hybridization is needed to understand how crop genes, including transgenes, affect the population genetics and ecology of sexually compatible relatives. Transgenic sorghum is under development for use by traditional farmers in Africa, the center of origin for sorghum [Sorghum bicolor (L.) Moench], but systematic surveys of the current extent of cont...

Weedy plant species that have evolved resistance to herbicides due to enhanced metabolic capacity to detoxify herbicides (metabolic resistance) are a major issue. Metabolic herbicide resistance in weedy plant species first became evident in the 1980s in Australia (in Lolium rigidum) and the United Kingdom (in Alopecurus myosuroides) and is now increasingly recognized in several crop-weed specie...

Several studies have expressed concerns about the effects of gene flow from transgenic herbicide-resistant crops to their wild relatives, but no major problems have been observed. This review describes a case study in which what has been feared in transgenics regarding gene flow has actually changed biodiversity and people's lives. Nontransgenic imidazolinone-resistant rice (IMI-rice) cultivars...

field studies were conducted at lorestan, kermanshah and golestan provinces in 2006 to separately evaluation of clethodim herbicide for weedy grass control in soybean. all experiments were designed as randomized complete blocks with four replicates. treatments included: clethodim at 0.6, 0.8, 1, and 1.2 l/ha; cycloxydim at 3 l/ha; haloxyfop-r-methyl at 0.75 l/ha; quizalofop-p-ethyl at 2 l/ha; a...

For patients with Relapsing Remitting Multiple Scierosis Beta Interfaerons and Glatiramer Acetate were the first to be licensed for treatment. This review deals with one major question: when to initiate therapy? Through exploring the unique characteristics of the disease and treatement we suggest an approach that should be helpful in the process of decision-making.